Attorney General Ken Paxton of Texas is launching an investigation into two pharmaceutical companies that are accused of violating the Texas Deceptive Trade Practices Act by promoting puberty [.]
Texas Attorney General Ken Paxton announced an investigation into two pharmaceutical companies that allegedly promoted hormone blocking drugs for children with gender dysphoria, even though the drugs have not been approved for this purpose. One of the companies told Fox News that it has not promoted the drugs for gender dysphoria.
The FDA has not approved these drugs for gender dysphoria Texas Attorney General Ken Paxton announced an investigation into two pharmaceutical companies that allegedly promoted hormone-blocking drugs for children with gender dysphoria, even.
Texas Attorney General Ken Paxton (R) this week announced that his office will investigate two pharmaceutical companies accused of promoting hormone-blocking drugs for children with gender dysphoria despite the drugs not having